AZ launches branded YouTube channel, testimonial site

Share this article:

AstraZeneca (AZ) launched a branded YouTube channel today for its asthma drug Symbicort, as well as My Asthma Story (myasthmastory.com), a website calling for testimonial videos.

The YouTube channel and “vlog” (video blog) feature testimonial videos in widescreen, where patients describe their experiences with Symbicort. Some risk information scrolls across the bottom margin of the videos while they play, and a link to full PI information appears near the top of the channel page. Other fair balance information appears elsewhere on the page. The channel also directs consumers to myasthmastory.com, where Symbicort users are invited to upload videos about their own experiences with the drug.

According to Dana Settembrino, senior brand communications manager at AZ, the videos submitted on myasthmastory.com will be reviewed by a panel of legal, regulatory and compliance experts, with their selections appearing on the Symbicort YouTube channel.  Videos appearing on the YouTube channel are not open for comment by viewers.

The YouTube channel and the My Asthma Story website were created by Digitas and Cadient, and allow asthma-sufferers to “share patient stories about controlling asthma,” said Settembrino.  “[The channel and website] is a way to engage patients and maintain a conversation,” she said.

Share this article:

Email Newsletters

More in News

Five things for pharma marketers to know: Friday, August 22

Five things for pharma marketers to know: Friday, ...

Two new indications give Eliquis more juice, a new rule is making hydrocodone harder to get and the ALS Ice Bucket Challenge highlights a controversial aspects of drug discovery and ...

Lilly takes on Amgen's Enbrel

Lilly takes on Amgen's Enbrel

Phase-III tests indicate Lilly's experimental treatment bests Amgen's for moderate-to-severe plaque psoriasis.

GSK Ellipta franchise expands

GSK Ellipta franchise expands

The FDA has approved Arnuity Ellipta for asthma.